Home » Topics » Regulatory » Patents

Patents
RSS

NOS-inhibitory condensed piperidines disclosed by Ono

Nov. 12, 1998

Proton pump inhibitors in the pipeline at Yuhan

Nov. 11, 1998

Nicotinic acetylcholine receptor ligands for nicotine addiction and CNS disorders

Nov. 11, 1998

Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis

Nov. 11, 1998

Chugai describes inhibitors of iNOS, nNOS

Nov. 11, 1998

Selective inhibitors of vascular wall, microsomal ACAT developed at Kowa

Nov. 11, 1998

Pharmacia & Upjohn patents new agents for CNS and neurodegenerative disorders

Nov. 10, 1998

New series from Agouron with inhibitory activity against MMPs and TNF-alpha production

Nov. 10, 1998

Noncytotoxic thiocolchicine derivatives useful as muscle relaxants

Nov. 10, 1998

Compounds acting on metabotropic glutamate receptors disclosed by Lilly

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.